Translation of Pritikin Program to the Community
Prit-TN
Population-Based Lifestyle Intervention: Translation of the Pritikin Program to the Community- Pilot Study Protocol
1 other identifier
interventional
54
1 country
1
Brief Summary
The broad, long-term aims of this scope of work are to investigate the effects of the Pritikin Program to the general population. The study will test the effects on individuals from the community with dysfunctional lipids, blood pressure and glycemic control. To assess the effectiveness of the Pritikin Program in the community, the effects of Pritikin lifestyle intervention on overall health will be investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 27, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedFirst Submitted
Initial submission to the registry
April 24, 2019
CompletedFirst Posted
Study publicly available on registry
April 26, 2019
CompletedMay 8, 2019
May 1, 2019
2 months
April 24, 2019
May 6, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Body Weight
6 weeks
Blood Pressure
6 weeks
Cholesterol
6 weeks
Triglycerides
6 weeks
Study Arms (2)
Intervention
EXPERIMENTALThe intervention group participated in a 6-week Pritikin diet, exercise program, and behavioral modification.
Control
NO INTERVENTIONThis group did not receive any intervention.
Interventions
Eligibility Criteria
You may qualify if:
- Dysfunctional lipids, blood pressure and glycemic control determined at a screening visit:
- Triglycerides \> 150 mg/dL OR HDL \<50 in females, \<40 mg/dL in males
- Systolic blood pressure ≥130 mmHg OR diastolic blood pressure ≥80 mmHg (or on hypertension medication)
- HbA1c ≥5.7% or higher
- No diagnosis or treatment for cancer in the past year
- No diagnosis of mild cognitive impairment or dementia in the past year
- Ability to perform daily exercise, including aerobic activity and resistance exercise
- Non-smoker in the past year
You may not qualify if:
- Positive exercise stress test
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Washington University School of Medicinelead
- Pritikin Longevity Centercollaborator
- Wellmont Health Systemcollaborator
Study Sites (1)
Washington University in St. Louis
St Louis, Missouri, 63110, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2019
First Posted
April 26, 2019
Study Start
September 27, 2018
Primary Completion
November 20, 2018
Study Completion
December 1, 2018
Last Updated
May 8, 2019
Record last verified: 2019-05